PEAR

Pear Therapeutics, Inc. Class A Common Stock
PEAR

Delisted

PEAR was delisted on the 18th of April, 2023.

Back to rankings

72 hedge funds and large institutions have $203M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13.9M
2
+$12.9M
3
+$11.9M
4
Nomura Holdings
Nomura Holdings
Japan
+$11.6M
5
Citadel Advisors
Citadel Advisors
Florida
+$9.89M

Top Sellers

1
-$13.5K
2
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.96M
27
$2.74M
28
$2.47M
29
$2.13M
30
$2.08M
31
$2.04M
32
$1.98M
33
$1.87M
34
$1.48M
35
$1.48M
36
$1.48M
37
$1.48M
38
$1.38M
39
$1.29M
40
$1.27M
41
$1.24M
42
$989K
43
$988K
44
$988K
45
$858K
46
$692K
47
$604K
48
$497K
49
$495K
50
$494K
1
2
3